中文名稱：小鼠抗CDKN2A單克隆抗體

英文名稱： Anti-CDKN2A mouse monoclonal antibody

別名： cyclin dependent kinase inhibitor 2A; ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P

相關類別：一抗

儲存： 冷凍（-20℃）

宿主： Mouse

抗原： CDKN2A

反應種屬： Human

標記物： Unconjugate

克隆類型： mouse monoclonal

技術規(guī)格

Background:

This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.

Applications:

WB, IHC, FC

Name of antibody:

CDKN2A

Immunogen:

Fusion protein of human CDKN2A

Full name:

cyclin dependent kinase inhibitor 2A

Synonyms:

ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A

SwissProt:

P42771

IHC positive control:

Human lung cancer and Human ovarian cancer

IHC Recommend dilution:

200-500

WB Predicted band size:

17 KD

WB Positive control:

293T and Hela cell lysates

WB Recommended dilution:

500-2000

FC Recommend dilution:

50-100

展開全部

小鼠抗CDKN2A單克隆抗體說明書
下載

久久综合九九-久久综合九九亚洲一区-久久综合九色-久久综合九色欧美综合狠狠-久久综合九色婷婷97-久久综合九色综合8888

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細胞系

細胞庫

基礎培養(yǎng)基

完全培養(yǎng)基

原代細胞

細胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標準品

血清

形態(tài)病理檢測

分子病理

超微病理

產(chǎn)品中心

最新產(chǎn)品

相關文章

小鼠抗CDKN2A單克隆抗體

Background:	This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.
Applications:	WB, IHC, FC
Name of antibody:	CDKN2A
Immunogen:	Fusion protein of human CDKN2A
Full name:	cyclin dependent kinase inhibitor 2A
Synonyms:	ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A
SwissProt:	P42771
IHC positive control:	Human lung cancer and Human ovarian cancer
IHC Recommend dilution:	200-500
WB Predicted band size:	17 KD
WB Positive control:	293T and Hela cell lysates
WB Recommended dilution:	500-2000
FC Recommend dilution:	50-100